Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
The Reality of MarTech for Pharma in India: What the Leaders Do vs. What You Still Haven’t
Let’s not pretend. Some pharma brands in India are miles ahead with tech-led marketing. Most others are still stuck in 2015; they're still running scattered campaigns, using basic CRMs, and…
|
The Real Cost of Not Investing in a Doctor Engagement Platform in India
Let’s get straight to it. If you’re leading marketing at a pharma company in India and still don’t have a dedicated Doctor Engagement Platform in India, you’re already behind. Not behind on trends.…
|
Why 2025 Is the Last Year Pharma CMOs Can Afford to Ignore MarTech ROI
There’s no polite way to say it. Most Indian pharma CMOs have underinvested in MarTech. Not because they’re unaware, but because the industry has allowed them to delay. The compliance shield. The…
|
Pharma case studies: 5 Real Campaigns That Increased Doctor Engagement by 3X (Case Studies Inside)
Let’s not overcomplicate it. If you’re running marketing in pharma and you’re serious about results, you need a doctor engagement platform India that actually drives interaction. Not once. Not…
